Three-dimensional structure prediction of the interaction of CD34 with the SH3 domain of Crk-L

Stem Cells and Development

Volumn 14, Issue 5, 2005, Pages 470-477

  Gangenahalli, Gurudutta U ^a,c   Singh, Vimal K ^a,b   Verma, Yogesh K ^a,b   Gupta, Pallavi ^a   Sharma, Rakesh K ^a   Chandra, Ramesh ^b   Gulati, Shweta ^a   Luthra, Pratibha M ^b  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b UNIVERSITY OF DELHI   (India)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CELL PROTEIN; CONNEXIN 43; CRK LIKE PROTEIN; GLUTAMIC ACID; SERINE;

ALPHA HELIX; ARTICLE; BETA SHEET; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SUSPENSION; CELL TRANSFORMATION; CELL VIABILITY; CYTOPLASM; HEMATOPOIETIC STEM CELL; HUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; STEREOCHEMISTRY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANTIGENS, CD34; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; REPRODUCIBILITY OF RESULTS; SEQUENCE ALIGNMENT; SRC HOMOLOGY DOMAINS; STEM CELLS;

EID: 28844446971     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2005.14.470     Document Type: Article

References (45)

1. + cell counts in stem cell graft. Stem Cells 17:272-276.
2. Krause DS, MJ Fackler, CL Civin and WS May. (1996). CD34: structure, biology and clinical utility. Blood 87:1-13.
3. Civin CL, LC Strauss, C Brovall, MJ Fackler, JF Schwartz and JH Shaper. (1984). Antigenic analysis of hematopoiesis III; A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-a cells. J Immunol 133:157-165.
4. Bhatia M, JC Wang, U Kapp, D Bonnet and JE Dick. (1997). Purification of primitive human, hematopoietic cells capable of repopulating immunodefficient mice. Proc Natl Acad Sci USA 94:5320-5325.
5. Lanza F, L Healy and DR Sutherland. (2001). Structural and functional features of the D34 antigen: an update. J Biol Regl Homeost Agents 15:1-13.
6. Gordan MY, SB Marley and R Davidson. (2000). Contact mediated inhibition of human hematopoietic progenitors cell proliferation may be conferred by stem cell antigen CD34. Hematol J 1:77-86.
7. Fackler M, DS Krause, OM Smith, CI Civin and WS May. (1995). Full length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 85:3040-3047.
8. Baumhueter S, SS Marks and H William. (1993). Binding of L-selectin to the vascular sialomucin CD34. Science 262:436-438.
9. Lyn H, G May, K Gale, F Grosveld, M Greaves and T Enver. (1995). The stem cell antigen CD34 functions as a regulator of hematopoietic cell adhesion. Proc Natl Acad Sci USA 92:12240-12244.
10. Donna MF, ML McVeigh, GT Hoehn, CI Civin and MJ Fackler. (2001). The adapter protein Crk-L associates with CD34. Blood 97:3768-3775.
11. Arai A, Y Nosaka, H Kohsaka, N Miyasaka and O Miura. (1999). Crk-L activates integrin Mediated hematopoietic cell adhesion through guanine nucleotide exchange factor C3G. Blood 93:3713-3722.
12. Feller SM, R Ren, H Hanafusa and D Baltimore. (1994). SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. Trends Biochem. Sci. 19:453-59.
13. ten Hoeve J, C Morris and N Heisterkamp. (1993). Isolation and chromosomal localization of Crk-L, a human Crk like gene. Oncogene 8:2459-2474.
14. Barber DL, JM Mason, T Fukazawa, KA Reedquist, BJ Druker, H Band and AD D'Andrea. (1997). Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adapter proteins. Blood 89:3166-3174.
15. Oda A, Y Miyakawa, BJ Druker, A Ishida, K Ozaki, H Ohashi, M Wakui, M Handa, K Watanabe, S Okamoto and Y Ikeda. (1996). Crk-L is constitutively phosphorylated in platelets from chronic myelogenous leukemia patients and inducible phosphorylated in normal platelets stimulated by thrombopoietin. Blood 88:4304-4313.
16. Sattler M, R Salgia, G Shrikhande, S Verma, E Pisick, KVS Prasad and DG James. (1997). Steel factor induces tyrosine phosphorylation of Crk-L and binding of Crk-L to a complex containing c-kit phosphaatidylinositol, 3-kinase, and p120 (CBL). J Biol Chem 272:10248-10253.
17. Uemura N and JD Griffin. (1999). The adapter protein Crk-L links Cbl to C3G after integrin ligation and enhances cell migration. J. Biol. Chem 274:37525-37532.
18. Nosaka Y, A Arai and N Miyasaka. (1994). Crk-L mediates Ras-dependent activation of the Raf/ERK through guanine nucleotide exchange factor C3G in hematopoietic cells stimulated with erythropoietin or interleukin-3. J Biol Chem 272:30154-39162.
19. Robertson H, WY Langdon, CB Thien and DDL Bowtell. (1997). A c-Cbl yeast two hybrid screen reveals interactions with 14-3-3 isoforms and cytoskeletal components. Biochem Biophys Res Commun 240:46-50.
20. Liu Y, Y-C Liu, N Meller, L Giampa, C Elly, M Doyle and A Altman. (1999). Protein kinase C activation inhibits tyrosine phosphorylation of Cbl and its recruitment of Src homology 2 domain-containing proteins. J Immunol 162: 7095-7101.
21. Dolfi F, M Garcia-Guzman, M Ojaniemi, H Nakamura, M Matsuda and K Vuori. (1998). The adaptor protein Crk connects multiple cellular stimuli to the JNK signaling pathway. Proc Natl Acad Sci USA 95:15394-15399.
22. Wu X, B Kudsen, SM Feller, J Zheng, A Sali, D Cowburn, H Hanafusa and J Kuriyan. (1995). Structural basis for the specific interaction of Lysine containing pralinerich peptides with the N-terminal SH3 domain of c-Crk. Structure 3:215-226.
23. Musacchio A, M Saraste and M Wilmanns. (1994). High-resolution crystal structure of tyrosine kinase SH3 domain complexed with proline rich peptide. Nature Struct Biol 1:546-551.
24. Kay BK, MP Wiliomson and M Sudol. (2000). The importance of being proline: the interaction of proline rich motifs in signaling proteins with their cognate domains. FASEB J 14:231-241.
25. Mayer BJ. (2001). SH3 domains: complexity in moderation. J Cell Sci 114:1253-1263.
26. Williams JC, A Weijland, S Gonfloni, A Thompson, SA Courtneidge, G Superti-Furga and RK Wierenga. (1997). The 2.5 A crystal structure of the inactivated form of chicken Src, A dynamic molecule with muliple regulatory interactions. J Mol Biol 274:757-775.
27. Moniovi AM, PR Romano, S Panni, M Mendoza, WT Wong, A Musacchio, G Cesareni and P Di Fiore. (1999). A novel peptide SH3 interaction. EMBO J 18:5300-5309.
28. Kato M, K Miyazawa and N Kitamura. (2000). A deubiquitinating enzyme UBPY interacts with the Src homology3 domain of Hrs binding protein via a Novel binding motif PXP[V/I][D/N]RXXKP. J Biol Chem 275:37481-37487.
29. Lewitzsky M, C Kardinal, NH Gehring, EK Schmidt, B Konkol, M Eulitz, W Birchmeier, U Schaeper and SM Feller. (2001). The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequence in Gabi and SLP-76 which lack the SH3 typical PxxP core motif. Oncogene 20:1052-1062.
30. Kang H, C Freund, JS Duke-Kohan, A Musacchio, G Wagner and CE Rudd. (2000). SH3 domain recognition of a proline independent tyrosine based RKxxxYxY motif in immune cell adapter SKAP55. EMBO J 19:2889-2899.
31. Barnett P, G Bottger, TJA Klein, HF Tabak and B Distel. (2000). The Peroxisomal membrane Protein Pex13p shows a novel mode of SH3 interaction. EMBO J 19:6382-6391.
32. Urquhart AJ, D Kennady and SJ Gould. (2000). Interaction of Pex5p,the type I peroxisome target receptor, with the Peroxisomal membrane proteins Pex14p and Pex 13P. J Biol Chem 275:4127-4136.
33. Sorgen PL, HS Duffy, P Sahoo, W Coombs, M Delmar and DC Spray. (2004). Structural changes in the carboxyl terminus of the gap junction protein connexin 43 indicates signaling between binding domain for c-Src and zonila occludens-1. J Biol Chem 279:54695-54701.
34. Ginalski K, M Grotthuss, NV Grishin and L Rychlewski. (2004). Detecting distant homology with MetaBASIC. Nucleic Acids Res 32 (Web server issue):W576-W581.
35. von Grothuss M, PJ Wrrwicz, K Ginalski and L Rychlewski. (2003). Application of the 3-D jury, GRDB and Veryfy 3D in fold recognition. Proteins 53:18-423.
36. Guesx N, A Diemand and MC Peitsch. (1999). Protein modeling for all. Trends Biochem 24:64-67.
37. Laskowaski RA, MW Mac Arthur, DS Moss and JM Thorton. (1993). PROCHECK: a program to check the stereo-chemical quality of protein structure. J Appl Cryst 26:281-293.
38. Hooft RWW, G Vriend, C Sender, and EE Abola. (1996). Errors in protein structures. Nature 381:272-272.
39. Ritchie DW. (2003). Evaluation of protein docking predictions using Hex 3.1 in CAPRI rounds 1 and 2. PROTEINS: Struct Funct Genet 52:98-106. (Accessible at http://www.csd.abdn.ac.uk/hex/.
40. Luthy R, JU Bowie, and D Eisenberg. (1992). Assessment of protein models with three-dimensional profiles. Nature 356:83-85.
41. Fraternali F and L Cavallo. (2002). Parameter optimized surfaces (POPS): Analysis of Key interactions and conformational changes in the ribosome. Nucleic Acids Res 30:2950-2960.
42. Cavallo L, J Kleinjung, and F Fraternali. (2003). POPS: a fast algorithm for solvent accessible surface areas at atomic and residue level. Nucleic Acids Res 31:3364-3366.
43. Michalopoulos I, GM Torrance, DR Gilbert and DR Westhead. (2004). TOPS: an enhanced database of protein structural topography. Nucleic Acids Res 32:D251-254, data-base issue.
44. Smit L, G van der Horst and J Borst. (1996). Sos, Vav and C3G participate in B-cell receptor-induced signaling pathway and differentially associates with shc-Grb2, Crk and Crk-L adapters. J Biol Chem 271:8564-8569.
45. Yaffe MB, GG Leparc, J Lai, T Obata, S Volinia and LC Cantley. (2001). A motif-based profile scanning approach for genome wide prediction of signaling pathways. Nature Biotechnol 19:348-353.